UniversitaetsSpital Zuerich

Site:	UniversitaetsSpital Zuerich
Address:
City:	Zurich
State:
Zip:	CH-8091
Country:	Switzerland

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors	Ongoing, but not recruiting	Closed	Dasatinib (BMS-354825)	NCT00568750
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501